A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression

Glycobiology

Volumn 18, Issue 12, 2008, Pages 1105-1118

  Abd Hamid, Umi M ^a,e   Royle, Louise ^b,e   Saldova, Radka ^a,e   Radcliffe, Catherine M ^c,e   Harvey, David J ^e   Storr, Sarah J ^f   Pardo, Maria ^d,e   Antrobus, Robin ^e   Chapman, Caroline J ^f   Zitzmann, Nicole ^e   Robertson, John F ^f   Dwek, Raymond A ^e   Rudd, Pauline M ^a,e  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b Culham Science Centre   (United Kingdom)

^c LONZA AG   (Switzerland)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Acute phase proteins; Biomarker; Breast cancer; N linked glycans; sLex

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTICHYMOTRYPSIN; BIOLOGICAL MARKER; CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GLYCAN; GLYCOPROTEIN; HAPTOGLOBIN; OROSOMUCOID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METASTASIS; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE PROGRESSION; FEMALE; GLYCOPROTEINS; HUMANS; MIDDLE AGED; POLYSACCHARIDES; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 57049137606     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwn095     Document Type: Article

References (49)

1. Bosmann HB, Hall TC. 1974. Enzyme activity in invasive tumors of human breast and colon. Proc Natl Acad Sci USA. 71:1833-1837.
2. Brinkman-van der Linden EC, de Haan PF, Havenaar EC, van Dijk W. 1998. Inflammation-induced expression of sialyl Lewis x is not restricted to alpha1-acid glycoprotein but also occurs to a lesser extent on alpha1-antichymotrypsin and haptoglobin. Glycoconj J. 15:177-182.
3. Chatterjee SK. Zetter BR. 2005. Cancer biomarkers: Knowing the present and predicting the future. Future Oncol. 1:37-50.
4. Crispin MD, Ritchie GE, Critchley AJ, Morgan BP, Wilson IA, Dwek RA, Sim RB, Rudd PM. 2004. Monoglucosylated glycans in the secreted human complement component C3: Implications for protein biosynthesis and structure. FEBS Lett. 566:270-214.
5. De Graaf TW, Van Der Stelt ME, Anbergen MG, van Dijk W. 1993. Inflammation-induced expression of sialyl Lewis x-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera. J Exp Med. 177:657-666.
6. Domon B, Costello CE. 1988. A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates. Glycoconj J 5:397-409.
7. Duan LL, Guo P, Zhang Y, Chen HL. 2005. Regulation of metastasis-suppressive gene Nm23-H1 on glycosyl-transferases involved in the synthesis of sialyl Lewis antigens. J Cell Biochem. 94:1248-1257.
8. Dube DH, Bertozzi CR. 2005. Glycans in cancer and inflammation - Potential for therapeutics and diagnostics. Nat Rev Drug Discov. 4:477-488.
9. Duffy MJ. 2006. Serum tumor markers in breast cancer: Are they of clinical value? Clin Chem. 52:345-351.
10. Fournet B, Montreuil J, Strecker G, Dorland L, Haverkamp J, Vliegenthart JFG, Binette JP, Schmid K. 1978. Determination of the primary structures of 16 asialo-carbohydrate units derived from human plasma alpha 1-acid glycoprotein by 360-MHZ 1H NMR spectroscopy and permethylation analysis. Biochemistry. 17:5206-5214.
11. Fukami A, Iijima K, Hayashi M, Komiyama K, Omura S. 2002. Macrosphelide B suppressed metastasis through inhibition of adhesion of sLe(x)/ E-selectin molecules. Biochem Biophys Res Commun. 291:1065-1070.
12. Fukuda M. 1996. Possible roles of tumor-associated carbohydrate antigens. Cancer Res. 56:2237-2244.
13. Gendler SJ, Dermer GB, Silverman LM, Tokes ZA. 1982. Synthesis of alpha 1-antichymotrypsin and alpha 1-acid glycoprotein by human breast epithelial cells. Cancer Res. 42:4567-4573.
14. Gornik O, Royle L, Harvey DJ, Radcliffe CM, Saldova R, Dwek RA, Rudd P, Lauc G. 2007. Changes of serum glycans during sepsis and acute pancreatitis. Glycobiology. 17:1321-1332.
15. Grabenhorst E, Nimtz M, Costa J, Conradt HS. 1998. In vivo specificity of human alpha1,3/4-fucosyltransferases III-VII in the biosynthesis of Lewis x and sialyl Lewis x motifs on complex-type N-glycans: Coexpression studies from bhk-21 cells together with human beta-trace protein. J Biol Chem. 273:30985-30994.
16. Hakomori S. 2001. Tumor-associated carbohydrate antigens defining tumor malignancy: Basis for development of anti-cancer vaccines. Adv Exp Med Biol. 491:369-402.
17. Harvey DJ. 1993. Quantitative aspects of the matrix-assisted laser desorption mass spectrometry of complex oligosaccharides. Rapid Commun Mass Spectrom. 7:614-619.
18. Harvey DJ. 2005. Fragmentation of negative ions from carbohydrates: Part 3. Fragmentation of hybrid and complex N-linked glycans. J Am Soc Mass Spectrom. 16:647-659.
19. Harvey DJ, Royle L, Radcliffe CM, Rudd PM, Dwek RA. 2008. Structural and quantitative analysis of N-linked glycans by matrix-assisted laser desorption ionization and negative ion nanospray mass spectrometry. Anal Biochem. 376:44-60.
20. Hassner A, Birnbaum D, Loew LM. 1984. Charge-shift probes of membrane potential synthesis. J Org Chem. 49:2546-2551.
21. Havenaar EC, Axford JS, Brinkman-van der Linden EC, Alavi A, Van Ommen EC, van het Hof B, Spector T, Mackiewicz A, Van Dijk W. 1998. Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in alpha3-fucosylation of alpha1-acid glycoprotein. Glycoconj J. 15:723-729.
22. Higai K, Ichikawa A, Matsumoto K. 2006. Binding of sialyl Lewis x antigen to lectin-like receptors on NK cells induces cytotoxicity and tyrosine phosphorylation of a 17-kDa protein. Biochim Biophys Acta. 1760:1355-1363.
23. Holmes EH, Ostrander GK, Hakomori S. 1986. Biosynthesis of the sialyl-Lex determinant carried by type 2 chain glycosphingolipids (IV3NeuAcIII3FucnLc4, VI3NeuAcV3FucnLc6, and VI3NeuAcII3V3Fuc2nLc6) in human lung carcinoma PC9 cells. J Biol Chem. 261:3737-3743.
24. Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N. 2004. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci. 95:377-384.
25. Kobata A, Amano J. 2005. Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours. Immunol Cell Biol. 83:429-439.
26. Kolarich D, Weber A, Turecek PL, Schwarz HP, Altmann F. 2006. Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoforms. Proteomics. 6:3369-3380.
27. Kurebayashi J, Nomura T, Hirono M, Okubo S, Udagawa K, Shiiki S, Ekeda M, Nakashima K, Tanaka K, Sonoo H. 2006. Combined measurement of serum sialyl Lewis x with serum CA15-3 in breast cancer patients. Jpn J Clin Oncol. 36:150-153.
28. Kyselova. Z, Mechref Y, Kang P, Goetz JA, Dobrolecki LE, Sledge GW, Schnaper L, Hickey RJ, Malkas LH, Novotny MV. 2008. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin Chem. 54:1166-1175.
29. Magnani JL. 2004. The discovery, biology, and drug development of sialyl Lea and sialyl Lex. Arch Biochem Biophys. 426:122-131.
30. Matsuura N, Narita T, Hiraiwa N, Hiraiwa M, Murai H, Iwase T, Funahashi H, Imai T, Takagi H, Kannagi R. 1998. Gene expression of fucosyl- and sialyl-transferases which synthesize sialyl Lewis x, the carbohydrate ligands for E-selectin, in human breast cancer. Int J Oncol. 12:1157-1164.
31. Matsuura N, Narita T, Mitsuoka. C, Kimura N, Kannagi R, Imai T, Funahashi H, Takagi H. 1997. Increased level of circulating adhesion molecules in the sera of breast cancer patients with distant metastases. Jpn J Clin Oncol. 27:135-139.
32. Mizuguchi S, Inoue K, Iwata T, Nishida T, Izumi N, Tsukioka T, Nishiyama N, Uenishi T, Suehiro S. 2006. High serum concentrations of sialyl Lewis(x) predict multilevel N2 disease in non-small-cell lung cancer. Ann Surg Oncol. 13:1010-1018.
33. Nakagoe T, Fukushima K, Itoyanagi N, Ikuta Y, Oka T, Nagayasu T, Ayabe H, Hara S, Ishikawa. H, Minami H. 2002. Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer. J Cancer Res Clin Oncol. 128:257-264.
34. Ohyama C, Kanto S, Kato K, Nakano O, Arai Y, Kato T, Chen S, Fukuda MN, Fukuda M. 2002. Natural killer cells attack tumor cells expressing high levels of sialyl Lewis x oligosaccharides. Proc Natl Acad Sci USA. 99:13789-13794.
35. Okuno K, Kawai I, Hirai N, Narimatsu H, Yasutomi M. 2003. Role of sialyl Lewis x in liver metastasis in view of liver-associated immunity. Hepatogastroenterology. 50:756-760.
36. Renkonen J, Paavonen T, Renkonen R. 1997. Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma. Int J Cancer. 74:296-300.
37. Royle L, Campbell MP, Radcliffe CM, White DM, Harvey DJ, Abrahams JL, Kim YG, Henry GW, Shadick NA, Weinblatt ME, et al. 2008. HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem. 376:1-12.
38. Royle L, Radcliffe CM, Dwek RA, Rudd PM. 2006. Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. Methods Mol Biol. 347:125-143.
39. Saldova R, Royle L, Radcliffe CM, Abd Hamid UM, Evans R, Arnold JN, Banks RE, Hutson R, Harvey DJ, Antrobus R, et al. 2007. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology. 17:1344-1356.
40. Sanchez JC, Rouge V, Pisteur M, Ravier F, Tonella L, Moosmayer M, Wilkins MR, Hochstraser DF. 1997. Improved and simplified in-gel sample application using reswelling of dry immobilized pH gradients. Electrophoresis. 18:324-327.
41. Shevchenko, A, Jensen ON, Podtelejnikov AV, Sagliocco F, Wilm M, Vorm O, Mortensen P, Boucherie H, Mann M. 1996. Linking genome and proteome by mass spectrometry: Large-scale identification of yeast proteins from two-dimensional gels. Proc Natl Acad Sci USA. 93:14440-14445.
42. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. 1985. Measurement of protein using bicinchoninic acid. Anal Biochem. 150:76-85.
43. Stewart JF, Rubens RD, Hoare S, Bulbrook RD, Kessel D. 1982. Sertim sialyl transferase levels in patients with metastatic breast cancer treated by chemotherapy. Br J Cancer. 46:208-212.
44. Tabares G, Radcliffe CM, Barrabes S, Ramirez M, Aleixandre RN, Hoesel W, Dwek RA, Rudd PM, Peracaula R, de Llorens R. 2006. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Glycobiology. 16:132-145.
45. Thompson DK, Haddow JE, Smith DE, Ritchie RF 1983. Elevated serum acute phase protein levels as predictors of disseminated-breast cancer. Cancer. 51:2100-2104.
46. Thompson S, Cantwell BM, Cornell C, Turner GA. 1991. Abnormally-fucosylated haptoglobin: A cancer marker for tumour burden but not gross liver metastasis. Br J Cancer. 64:386-390.
47. Thompson S, Turner GA. 1987. Elevated levels of abnormally-fucosylated haptoglobins in cancer sera. Br J Cancer. 56:605-610.
48. Yamaguchi A, Ding K, Maehara M, Goi T, Nakagawara G. 1998. Expression of nm23-H1 gene and sialyl Lewis x antigen in breast cancer. Oncology 55:357-362.
49. Yamamura J, Miyoshi Y, Tamaki Y, Taguchi T, Iwao K, Monden M, Kato K, Noguchi S. 2004. mRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers. Cancer Sci. 95:887-892.